Role of Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma

Por Carella, Angelo Michele
Publicado em 2012

Treatment of children and adolescents with Hodgkin’s Lymphoma without radiotherapy for patients in complete remission after chemotherapy

Por Carella, Angelo Michele
Publicado no Transl Pediatr (2013)

Time Savings with Rituximab Subcutaneous Injection versus Rituximab Intravenous Infusion: A Time and Motion Study in Eight Countries

Por De Cock, Erwin, Kritikou, Persefoni, Sandoval, Mariana, Tao, Sunning, Wiesner, Christof, Carella, Angelo Michele, Ngoh, Charles, Waterboer, Tim
Publicado no PLoS One (2016)

High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy: long-term res...

Por Carella, Angelo Michele, Bellei, Monica, Brice, Pauline, Gisselbrecht, Christian, Visani, Giuseppe, Colombat, Philippe, Fabbiano, Francesco, Donelli, Amedea, Luminari, Stefano, Feugier, Pierre, Browett, Peter, Hagberg, Hans, Federico, Massimo
Publicado em 2009

Therapy of Hodgkin’s lymphoma in clinical practice: A retrospective long-term follow-up analysis

Por AQUINO, SARA, CLAVIO, MARINO, ROSSI, EDOARDO, VIGNOLO, LUANA, MIGLINO, MAURIZIO, SPRIANO, MAURO, CANEPA, LETIZIA, CATANIA, GIOACCHINO, PIERRI, IVANA, BERGAMASCHI, MICAELA, GONELLA, ROBERTA, MARANI, CARLO, RACCHI, OMAR, CAVALIERE, MARINA, GORETTI, RICCARDO, CARBONE, FEDERICO, BRUZZONE, ANDREA, TASSARA, RODOLFO, CARELLA, ANGELO MICHELE, GHIO, RICCARDO, GOBBI, MARCO
Publicado em 2011

Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a ph...

Por Chiappella, Annalisa, Tucci, Alessandra, Castellino, Alessia, Pavone, Vincenzo, Baldi, Ileana, Carella, Angelo Michele, Orsucci, Lorella, Zanni, Manuela, Salvi, Flavia, Liberati, Anna Marina, Gaidano, Gianluca, Bottelli, Chiara, Rossini, Bernardo, Perticone, Sonia, De Masi, Pasqualina, Ladetto, Marco, Ciccone, Giovannino, Palumbo, Antonio, Rossi, Giuseppe, Vitolo, Umberto
Publicado em 2013

Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM

Por Jakubowiak, Andrzej, Offidani, Massimo, Pégourie, Brigitte, De La Rubia, Javier, Garderet, Laurent, Laribi, Kamel, Bosi, Alberto, Marasca, Roberto, Laubach, Jacob, Mohrbacher, Ann, Carella, Angelo Michele, Singhal, Anil K., Tsao, L. Claire, Lynch, Mark, Bleickardt, Eric, Jou, Ying-Ming, Robbins, Michael, Palumbo, Antonio
Publicado no Blood (2016)

Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Itali...

Por Sacchi, Stefano, Marcheselli, Raffaella, Bari, Alessia, Buda, Gabriele, Molinari, Anna Lia, Baldini, Luca, Vallisa, Daniele, Cesaretti, Marina, Musto, Pellegrino, Ronconi, Sonia, Specchia, Giorgina, Silvestris, Franco, Guardigni, Luciano, Ferrari, Angela, Chiapella, Annalisa, Carella, Angelo Michele, Santoro, Armando, Di Raimondo, Francesco, Marcheselli, Luigi, Pozzi, Samantha
Publicado no Haematologica (2016)

Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients

Por Castagnetti, Fausto, Breccia, Massimo, Gugliotta, Gabriele, Martino, Bruno, D’Adda, Mariella, Stagno, Fabio, Carella, Angelo Michele, Avanzini, Paolo, Tiribelli, Mario, Trabacchi, Elena, Visani, Giuseppe, Gobbi, Marco, Salvucci, Marzia, Levato, Luciano, Binotto, Gianni, Capalbo, Silvana Franca, Bochicchio, Maria Teresa, Soverini, Simona, Cavo, Michele, Martinelli, Giovanni, Alimena, Giuliana, Pane, Fabrizio, Saglio, Giuseppe, Rosti, Gianantonio, Baccarani, Michele
Publicado no Haematologica (2016)

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, mult...

Por Ravandi, Farhad, Ritchie, Ellen K., Sayar, Hamid, Lancet, Jeffrey E., Craig, Michael D., Vey, Norbert, Strickland, Stephen A., Schiller, Gary J., Jabbour, Elias, Erba, Harry P., Pigneux, Arnaud, Horst, Heinz-August, Recher, Christian, Klimek, Virginia M., Cortes, Jorge, Roboz, Gail J., Odenike, Olatoyosi, Thomas, Xavier, Havelange, Violaine, Maertens, Johan, Derigs, Hans-Günter, Heuser, Michael, Damon, Lloyd, Powell, Bayard L., Gaidano, Gianluca, Carella, Angelo-Michele, Wei, Andrew, Hogge, Donna, Craig, Adam R., Fox, Judith A., Ward, Renee, Smith, Jennifer A., Acton, Gary, Mehta, Cyrus, Stuart, Robert K., Kantarjian, Hagop M.
Publicado no Lancet Oncol (2015)

Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

Por Broccoli, Alessandro, Pellegrini, Cinzia, Di Rocco, Alice, Puccini, Benedetta, Patti, Caterina, Gini, Guido, Mannina, Donato, Tani, Monica, Rusconi, Chiara, Romano, Alessandra, Vanazzi, Anna, Botto, Barbara, Carlo-Stella, Carmelo, Hohaus, Stefan, Musto, Pellegrino, Mazza, Patrizio, Molica, Stefano, Corradini, Paolo, Fama, Angelo, Gaudio, Francesco, Merli, Michele, Gravetti, Angela, Gritti, Giuseppe, Arcari, Annalisa, Tosi, Patrizia, Liberati, Anna Marina, Pinto, Antonello, Pavone, Vincenzo, Gherlinzoni, Filippo, Naso, Virginia, Volpetti, Stefano, Trentin, Livio, Goldaniga, Maria Cecilia, Bonfichi, Maurizio, De Renzo, Amalia, Schiavotto, Corrado, Spina, Michele, Storti, Sergio, Carella, Angelo Michele, Stefoni, Vittorio, Argnani, Lisa, Zinzani, Pier Luigi
Publicado no Haematologica (2017)

Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin’s lymphoma

Por Pellegrini, Cinzia, Broccoli, Alessandro, Pulsoni, Alessandro, Rigacci, Luigi, Patti, Caterina, Gini, Guido, Mannina, Donato, Tani, Monica, Rusconi, Chiara, Romano, Alessandra, Vanazzi, Anna, Botto, Barbara, Santoro, Armando, Hoaus, Stefan, Rigolin, Gian Matteo, Musto, Pellegrino, Mazza, Patrizio, Molica, Stefano, Corradini, Paolo, Fama, Angelo, Gaudio, Francesco, Merli, Michele, Ronconi, Fioravante, Gritti, Giuseppe, Vallisa, Daniele, Tosi, Patrizia, Liberati, Anna Marina, Pinto, Antonello, Pavone, Vincenzo, Gherlinzoni, Filippo, Bianchi, Maria Paola, Volpetti, Stefano, Trentin, Livio, Goldaniga, Maria Cecilia, Bonfichi, Maurizio, De Renzo, Amalia, Schiavotto, Corrado, Spina, Michele, Carella, Angelo Michele, Stefoni, Vittorio, Argnani, Lisa, Zinzani, Pier Luigi
Publicado no Oncotarget (2017)

Targeting Mutant BRAF with Vemurafenib in Relapsed or Refractory Hairy Cell Leukemia

Por Tiacci, Enrico, Park, Jae H., De Carolis, Luca, Chung, Stephen S., Broccoli, Alessandro, Scott, Sasinya, Zaja, Francesco, Devlin, Sean, Pulsoni, Alessandro, Chung, Young Rock, Cimminiello, Michele, Kim, Eunhee, Rossi, Davide, Stone, Richard M., Motta, Giovanna, Saven, Alan, Varettoni, Marzia, Altman, Jessica K., Anastasia, Antonella, Grever, Michael R., Ambrosetti, Achille, Rai, Kanti R., Fraticelli, Vincenzo, Lacouture, Mario E., Carella, Angelo Michele, Levine, Ross L., Leoni, Pietro, Rambaldi, Alessandro, Falzetti, Franca, Ascani, Stefano, Capponi, Monia, Martelli, Maria Paola, Park, Christopher Y., Pileri, Stefano Aldo, Rosen, Neal, Foà, Robin, Berger, Michael F., Zinzani, Pier Luigi, Abdel-Wahab, Omar, Falini, Brunangelo, Tallman, Martin S.
Publicado no N Engl J Med (2015)